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Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterized by hypercoagula-
bility, venous and/or arterial thromboses, and miscarriages. APS can be diagnosed according to speciﬁc
criteria and is usually observed in young adults. We report a case of an elderly woman with past history
of thrombosis and miscarriages who developed severe brain parenchymal hemorrhage and extensive
thrombosis of the superior sagittal sinus due to APS. This case emphasizes that, although rare, APS may
be diagnosed in elderly individuals and require effective anticoagulation.
Copyright  2014, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction
Antiphospholipid syndrome (APS) is a systemic autoimmune
condition characterized by hypercoagulability. APS may be clini-
cally manifested by venous and/or arterial thromboses, and also by
miscarriages.1 The clinical criteria for the diagnosis of APS were
established in Sapporo, Japan, in 1998, and are thus known as the
Sapporo criteria.2 These criteria have good sensitivity and excellent
speciﬁcity, although 1e3% of systemic lupus and systemic lupus-
like conditions may overlap when using the Sapporo criteria and,
therefore, cause misdiagnosis of APS.2 Neurological manifestations
may be related to a variety of immune-mediated vascular and in-
ﬂammatory effects and, most of the time, the signs and symptoms
are related to ischemia and/or thrombosis.2 Antiphospholipid an-
tibodies may activate endothelial cells, platelets and coagulation
cascades, leading to ischemic stroke and/or thrombosis in patients
of all ages.1,3 However, the young adult population is the segment
most affected by APS, a condition that may even present a cata-
strophic and fatal course.3 APS is rarely diagnosed in the elderly. In
fact, APS in geriatric medicine is only very rarely considered in
cases of ischemic or thrombotic disease in older patients.Medical School, UNIMES, Rua
.
linical Gerontology & Geriatrics. P2. Case report
The patient was a 78-year-old Caucasian woman, born in Spain
and living in Brazil. Her medical history included breast cancer 6
years previously, high blood pressure and dyslipidemia, which
were all under control. One morning in February 2013, she pre-
sented a persistent and unusual headache accompanied by hypo-
sensitivity on the right side of her body. She sought emergency care
and underwent magnetic resonance imaging of her brain (Fig. 1).
The neurologist on duty put the patient in the intensive care unit
and made a diagnosis of hemorrhagic stroke. After 3 days, the pa-
tient was considerably better and was discharged from hospital.
One week later, she presented a partial seizure with secondary
generalization, after a day of intense headache and vomiting. The
family returned her to hospital. She was hemiplegic on the right
side, confused and disorientated, with aphasia. Twomore magnetic
resonance scans showed an extensive lesion in the left hemisphere
of her brain (Fig. 1). Her blood cell count showed low levels of
platelets, while serum biochemical tests did not show any abnor-
malities. Her brain angiogram showed a massive thrombosis in the
brain venous system (Fig. 1).
The family then mentioned that she had had three previous
thrombotic episodes in the left leg between the ages of 37 years and
42 years. The family alsomentioned threemiscarriages between the
agesof 30 years and35years. Thesemiscarriages hadoccurredmany
decades ago but there were no records of chromosomal disease.ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
 
Fig. 1. (A) Magnetic resonance image of hemorrhagic area in the dominant brain hemisphere. The arrow indicates the lesion in one of the images. (B) Brain angiography showing
extensive thrombosis of the superior sagittal sinus. The arrow indicates the lesion.
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normal values for activated prothrombin time, activated thrombin
time, C-reactive protein, protein S, Leyden factor V, and rheumatoid
factor; anticardiolipin antibody immunoglobulin (Ig)M ¼ 50 MPL-
U/mL (normal up to 40); anticardiolipin antibody IgG ¼ 52 MPL-U/
mL (normal up to 40); cytoplasm antinuclear factor ¼ 1:320;
antiphospholipid antibody ¼ 1.90 (normal up to 1.24). This latter
test was repeated after 12 weeks and the result remained the same.
Antibodies to b2-glycoprotein I (anti-b2GPI) of IgG were 29 U/mL
(reagent if>20 U/mL) and IgMwere 24U/mL (reagent if>17 U/mL).
The patient received warfarin and demonstrated gradual
improvement of her neurological signs and symptoms.
3. Discussion
APS is usually considered when a young adult presents throm-
bosis and/or repeated miscarriages. If this condition is not consid-
ered to be a possible diagnosis at a younger age, the patient willcontinue to have the disease and it may then manifest later in life.
Reports of APS in the elderly are so rare that it might even be
considered that APS does not form any part of the differential
diagnosis of thrombosis in the geriatric population. However, as
shown in the present case, APS can manifest at an older age in a
catastrophic manner, with massive brain venous thrombosis.4,5 The
success of neurological treatment will depend upon correct diag-
nosis and immediate and efﬁcient anticoagulation. One important
aspect to be added to the discussion is the possibility of systemic
lupus and secondary APS. Although all the criteria for APS were
satisﬁed, the positivity of antinuclear factor may direct the medical
team’s attention towards systemic lupus in the elderly, which is
also a rare medical condition.6e8 However, systemic lupus presents
other manifestations and the present case does not fulﬁll the
criteria for lupus. Although this diagnosis cannot be excluded
completely at this point, it is unlikely.
It is also important to emphasize that cerebral thrombosis may
manifest with hemorrhage as well. Thrombosis of cerebral veins or
J.B.B. Brooks et al. / Journal of Clinical Gerontology & Geriatrics 5 (2014) 96e9898sinuses can result in increased venular and capillary pressure. As
local venous pressure continues to rise, decreased cerebral perfu-
sion results in ischemic injury. Cytotoxic edema and disruption of
the bloodebrain barrier leads to vasogenic edema, that may
culminate in parenchymal hemorrhage.
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